Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Utz Brands Analyst Scoreboard Recent Ratings and Price Targets

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_Assets (3)
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Utz Brands Analyst Scoreboard Update

In the last three months, analysts have shared a range of perspectives on Utz Brands (NYSE: UTZ), with varying ratings from bullish to bearish. Here is a breakdown of recent ratings and insights:

Total Ratings:
– Bullish: 3
– Somewhat Bullish: 2
– Indifferent: 1
– Somewhat Bearish: 0
– Bearish: 0

Latest 30 Days:
– Bullish: 1
– Somewhat Bullish: 0
– Indifferent: 1
– Somewhat Bearish: 0
– Bearish: 0

12-Month Price Targets:
– Average Target: $19.42
– High Estimate: $20.50
– Low Estimate: $18.00

Recent actions by key analysts include:
– Matt McGinley from Needham upgraded the rating to Buy with a price target of $20.50.
– Brian Holland from DA Davidson maintained a Neutral rating with a price target of $20.00.
– John Baumgartner from Mizuho issued a Buy rating with a price target of $19.00.
– Michael Lavery from Piper Sandler upgraded the rating to Overweight with a price target of $18.00.
– Nik Modi from RBC Capital upgraded the rating to Outperform with a price target of $19.00.

Analysts’ adjustments reflect their evaluations of Utz Brands’ outlook in response to market conditions and company performance, highlighting changing dynamics in the industry.

UTZ Stock Analysis: Price Decline on March 1, 2024 – What Investors Need to Know

On March 1, 2024, UTZ stock experienced a slight decline in its performance. The stock closed at $17.69, which was a decrease of $0.65 or 3.54% from the previous market close. Additionally, in after-hours trading, the stock dropped a further $0.26. Despite the decrease in price on this particular day, UTZ is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, even though it experienced a slight dip on March 1st. Investors may be monitoring UTZ closely to see if this decline is a temporary fluctuation or the start of a larger downward trend. It is important to consider the overall market conditions and any specific news or events that may be impacting UTZ’s stock performance. As with any investment, it is essential for investors to conduct thorough research and analysis before making any decisions. Keeping track of price movements, technical indicators, and market trends can help investors make informed choices about their investments in UTZ or any other stock.

UTZ Brands, Inc. Financial Performance Review: Mixed Results on March 1, 2024

On March 1, 2024, UTZ Brands, Inc. (UTZ) had a mixed performance in terms of its financials. According to data from CNN Money, the company reported total revenue of $1.41 billion for the past year, which represents a 19.28% increase compared to the previous year. However, total revenue remained flat at $371.85 million for the last quarter. In terms of net income, UTZ reported a net loss of $392,000 for the past year, which is a significant decrease of 101.94% compared to the previous year. On the other hand, the company reported a net income of $15.99 million for the last quarter, marking a substantial increase of 487.8% compared to the previous quarter. Earnings per share (EPS) for UTZ also saw a mixed performance. The company reported an EPS of -$0.00 for the past year, which is a decrease of 101.97% compared to the previous year. However, EPS improved to $0.19 for the last quarter, representing an increase of 476.62% compared to the previous quarter. Overall, UTZ’s stock performances on March 1, 2024, reflect a company that has seen both positive and negative trends in its financial metrics. The increase in total revenue over the past year is a positive sign, but the significant decrease in net income for the same period raises concerns. The substantial increase in net income and EPS for the last quarter is a promising development, but investors may want to closely monitor UTZ’s financial performance in the coming quarters to assess its long-term sustainability.

Tags: UTZ
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Empowering the Next Generation enCore Energys Education Society and Scholarship Programs

Global supply chain

Goldman Sachs Analyst Bonnie Herzog Issues Sell Rating on Clorox

DVY stock news

Analysts Bullish on GoodRx Holdings Inc Following Strong Q4 FY23 Results

Recommended

Gerresheimer Stock

Gerresheimer Shares Plunge Amid Deepening Crisis

4 months ago
Alphabet Stock

Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance

4 months ago
Technology Data analytics stock Trading (1)

Revolutionizing Ad Monetization Brightcove and Google Ad Manager Join Forces

2 years ago
MMP stock news

Yousif Capital Management Reduces Holdings in Alarm.com, Inc. – Analyzing Impact on Future Prospects

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Trending

CrowdStrike Stock
Analysis

CrowdStrike Shares Face Headwinds Amid Mixed Signals

by Andreas Sommer
February 5, 2026
0

The investment case for cybersecurity leader CrowdStrike is currently being shaped by conflicting developments. Positive legal news...

NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026
Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CrowdStrike Shares Face Headwinds Amid Mixed Signals
  • NCR Voyix Charts a Course Toward Cloud-Centric Growth
  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com